Professor Wang Tuo's MDT team of the First Affiliated Council of Jiaotong University found that the first NTRK re -discharged intracranial tumor in China

Sunshine (Reporter Zheng Yalei) NTRK reinstallation of spidal cell tumors (NTRK-RearRANDLE CELL TUMOR) is a rare soft tissue tumor with NTRK genes. It is a set of soft tissue tumors defined by molecular genetic characteristics. Most tumors in this group occur in children and young people, and a few can occur in adults. Most of them are located in the human limbs, shallow trunk or deep soft tissue, and a few also affect the abdominal organs. However, in the past, the tumor thought that the tumor never invaded the cranial.

The rare cases discovered this time are the second case around the world. The first domestic NTRK reinvigation of snaphed cell tumor was originally in the case of intracranial cases. The discovery of this case is a typical case of clinical-scientific research transformation. It is in Xi'an Professor Wang Tuo Wang Tuo, Professor of the Department of neurosurgery of the First Academy of Jiaotong University, Professor Huilin, Department of Pathology, Professor Zhao Dongli, Department of Radio Restaline, the Department of Image Department of Maima, and Dr. Bian Yitong's MDT team discovered by the MDT team of intracranial complicated tumors. Pathological magazine.

Professor Wang Tuo's MDT team includes neurosurgery professional groups, pathology, image, radiotherapy, gamma knife therapy center and other neuroma -related departments. It is currently the only normal neuroma MDT team in the Northwest region. Patients benefit. It takes a multi -disciplinary discussion of complex intracranial tumors, providing patients with the treatment of complex tumor therapy for precision nervous systems, and maintaining a certain frequency academic exchanges with domestic Tiantan Hospital, Xuanwu Hospital, and West China Hospital. Professor Wang Tuo will continue to lead the intracranial complex tumor MDT team to continue to practice the concept, further explore minimally invasive treatment and multidisciplinary diagnosis and treatment strategies of intracranial complicated tumors to serve the majority of patients.

- END -